OpenCRISPR-1 Nuclease
Product Introduction
OpenCRISPR-1 is the world's first gene editor designed entirely by artificial intelligence. The research team at Profluent first systematically mined microbial genomic data totaling 26.2 terabases to construct the CRISPR-Cas Atlas database, containing over 1.24 million CRISPR operons. The Cas9 sequence diversity within this database is more than four times greater than that found in UniProt. Based on this massive dataset, the researchers fine-tuned the ProGen2 protein language model to generate 4.8 million novel CRISPR-associated protein sequences. Through rigorous screening and functional validation, they ultimately identified OpenCRISPR-1 as the top-performing candidate.
OpenCRISPR-1 consists of 1380 amino acids and maintains the typical bilobal architecture framework of type II Cas9 nucleases. However, its amino acid sequence differs from SpCas9 at over 400 positions and shares no more than 86% sequence similarity with any known naturally occurring CRISPR-associated protein. Despite this high degree of sequence divergence, AlphaFold2 structural predictions indicate that it fully retains key functional domains, including the HNH and RuvC nuclease domains. OpenCRISPR-1 recognizes the same 5'-NGG-3' PAM sequence as SpCas9 and can directly use standard SpCas9 sgRNAs, making it a plug-and-play replacement for existing SpCas9-based approaches.
Product Specifications
Parameter | Specification |
Source | Recombinant expression in E. coli |
Molecular Weight | ~160 kDa |
Concentration | 20 μM |
PAM Sequence | 5'-NGG-3' |
Cleavage Site | 3 bp upstream of PAM |
Cleavage Product | Blunt-ended DSB |
Similarity to SpCas9 | <86% |
Specificity | Higher than SpCas9 |
Purity | ≥95% (SDS-PAGE) |
Endotoxin | <1 EU/μg |
Storage Buffer | 50 mM Tris-HCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 50% Glycerol |
10× Reaction Buffer | 50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl₂, 100 μg/ml BSA, pH 7.9 |
Storage Conditions | Long-term storage at -80°C; short-term storage at -20°C |
Product Specifications
Specifications | Catalog Number | Concentration | Volume |
100 pmol | GR101601 | 20 μM | 5 μL |
500 pmol | GR101602 | 20 μM | 25 μL |
2500 pmol | GR101603 | 20 μM | 125 μL |
Application Scenarios
High-Specificity Gene Editing: Applications requiring reduced off-target risk.
Therapeutic Editing: Cell and gene therapy research and development.
Research Applications: As a substitute for SpCas9.
Intellectual Property Circumvention: Patent pathways independent of natural CRISPR systems.
AI Protein Design Validation: Validating the functionality of AI-designed proteins.
References
Ruffolo JA, et al. (2025). Design of highly functional genome editors by modelling CRISPR–Cas sequences. Nature. doi:10.1038/s41586-025-09298-z.